Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Blood–brain barrier dysfunction in multiple sclerosis: causes, consequences, and potential effects of therapies
Bettina Zierfuss, Catherine Larochelle, Alexandre Prat
The Lancet Neurology (2023) Vol. 23, Iss. 1, pp. 95-109
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Advancing neurological disorders therapies: Organic nanoparticles as a key to blood-brain barrier penetration
Zahra Razavi, Seyed Sina Alizadeh, F. S. Razavi, et al.
International Journal of Pharmaceutics (2025) Vol. 670, pp. 125186-125186
Open Access | Times Cited: 8
Crossing the blood–brain barrier: emerging therapeutic strategies for neurological disease
Josephine H Pedder, Adam M. Sonabend, Michael D Cearns, et al.
The Lancet Neurology (2025)
Closed Access | Times Cited: 3
Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies
Rahul Mallick, Sanjay Basak, Parimal Chowdhury, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 104-104
Open Access | Times Cited: 1
Ginsenoside Rb1 alleviates blood-brain barrier damage and demyelination in experimental autoimmune encephalomyelitis mice by regulating JNK/ ERK/NF-κB signaling pathway
Yingying Song, Xiaojuan Zhang, Xinyan Han, et al.
Journal of Ethnopharmacology (2025), pp. 119448-119448
Closed Access | Times Cited: 1
A New Perspective on Mechanisms of Neurodegeneration in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis: the Early and Critical Role of Platelets in Neuro/Axonal Loss
Jacqueline M. Orian
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Vascular models of Alzheimer's disease: An overview of recent in vitro models of the blood-brain barrier
Lily E Takeuchi, Lorraine V. Kalia, Craig A. Simmons
Neurobiology of Disease (2025), pp. 106864-106864
Open Access | Times Cited: 1
Single-cell dissection of the human blood-brain barrier and glioma blood-tumor barrier
Yuan Xie, Fan Yang, Liqun He, et al.
Neuron (2024) Vol. 112, Iss. 18, pp. 3089-3105.e7
Closed Access | Times Cited: 7
Blood–Brain Barrier Disruption in Neuroimmunological Disease
Fumitaka Shimizu, Masayuki Nakamori
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10625-10625
Open Access | Times Cited: 4
Comparative targeted lipidomics between serum and cerebrospinal fluid of multiple sclerosis patients shows sex and age-specific differences of endocannabinoids and glucocorticoids
Philip Meier, Sandra Glasmacher, Anke Salmen, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Role of the transcription factor NRF2 in maintaining the integrity of the Blood-Brain Barrier
Eduardo Cazalla, Antonio Cuadrado, Ángel J. García‐Yagüe
Fluids and Barriers of the CNS (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 4
Effect of electroacupuncture on MMP-2/9 pathway mediated the blood-brain barrier permeability in mice with Parkinson's disease
Xiaolei Zhang, Min Hu, Yanan Li, et al.
World Journal of Acupuncture - Moxibustion (2025)
Open Access
The canine blood-brain barrier in health and disease: focus on brain protection
Dimitri Bassalo, Stephen G. Matthews, Enrrico Bloise
Veterinary Quarterly (2025) Vol. 45, Iss. 1, pp. 12-32
Open Access
miRNA in blood-brain barrier repair: role of extracellular vesicles in stroke recovery
Vojtech Sprincl, Nataliya Romanyuk
Frontiers in Cellular Neuroscience (2025) Vol. 19
Open Access
Mendelian randomization identifies proteins involved in neurodegenerative diseases
Lazaros Belbasis, Sam Morris, Cornelia M. van Duijn, et al.
Brain (2025)
Closed Access
Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Boost Functional Performance in an Animal Model of Multiple Sclerosis Through Recruiting Oligodendrocytes and Attenuating Gliosis
S Mohammadhadi Mirab, Ameneh Omidi, Masoud Soleimani, et al.
Stem Cell Reviews and Reports (2025)
Closed Access
Impact of Peripheral Inflammation on Blood–Brain Barrier Dysfunction and Its Role in Neurodegenerative Diseases
Ana Isabel Beltrán-Velasco, Vicente Javier Clemente‐Suárez
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2440-2440
Open Access
Mitochondria transfer for myelin repair
Sabah Mozafari, Luca Peruzzotti‐Jametti, Stefano Pluchino
Journal of Cerebral Blood Flow & Metabolism (2025)
Closed Access
Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances
Xue Chen, Qingfei Chu, Qingmiao Shi, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
CXCL13 Damages Blood Spinal Cord Barrier by Promoting RNF6/Sqstm1‐Ubiquitination Induced Autophagy in Experimental Allergic Encephalomyelitis
Jingjing Han, Rui Hong, Cong Cao, et al.
Advanced Science (2025)
Open Access
Comprehensive Update on Multiple Sclerosis-Associated Uveitis and New Epidemiological Insights from the United Kingdom
Cara Heppell, Anuradhaa Subramanian, Nicola J. Adderley, et al.
Ocular Immunology and Inflammation (2025), pp. 1-13
Closed Access
The Janus Face of Astrocytes in Multiple Sclerosis: Balancing Protection and Pathology
Ahmad Abulaban, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Brain Research Bulletin (2025), pp. 111356-111356
Open Access
Blood-Brain Barrier Disruption in Neuroimmunological Disease
Fumitaka Shimizu, Masayuki Nakamori
(2024)
Open Access | Times Cited: 3
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK
James Blackstone, Thomas Williams, Jennifer Nicholas, et al.
BMJ Open (2024) Vol. 14, Iss. 9, pp. e086414-e086414
Open Access | Times Cited: 3
Integrating genetic and proteomic data to elucidate the association between immune system and blood-brain barrier dysfunction with multiple sclerosis risk and severity
Dongren Sun, Rui Wang, Qin Du, et al.
Journal of Affective Disorders (2024) Vol. 362, pp. 652-660
Closed Access | Times Cited: 2
circRNAs as Epigenetic Regulators of Integrity in Blood–Brain Barrier Architecture: Mechanisms and Therapeutic Strategies in Multiple Sclerosis
Elisabetta D’Aversa, Francesca Salvatori, Mauro Vaccarezza, et al.
Cells (2024) Vol. 13, Iss. 16, pp. 1316-1316
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top